Strata Skin Sciences, Inc. (NASDAQ:SSKN) shares were up 1.4% on Wednesday . The stock traded as high as $1.57 and last traded at $1.42. Approximately 25,433 shares changed hands during trading, a decline of 84% from the average daily volume of 162,417 shares. The stock had previously closed at $1.40.
Several research analysts have recently weighed in on SSKN shares. HC Wainwright reissued a “buy” rating and set a $7.00 price target on shares of Strata Skin Sciences in a research report on Friday, November 10th. Zacks Investment Research raised shares of Strata Skin Sciences from a “sell” rating to a “hold” rating in a research report on Thursday. Finally, ValuEngine cut shares of Strata Skin Sciences from a “sell” rating to a “strong sell” rating in a research report on Sunday, December 31st.
The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.07 and a current ratio of 1.64. The company has a market capitalization of $5.95, a PE ratio of -0.24 and a beta of 0.41.
Strata Skin Sciences Company Profile
STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.
Receive News & Ratings for Strata Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.